Search Results - "Passam, A M"
-
1
Significant involvement of CCR2–64I and CXCL12–3a in the development of sporadic breast cancer
Published in Journal of medical genetics (01-05-2004)Get full text
Journal Article -
2
The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance
Published in European journal of histochemistry (01-01-2005)“…Several prognostic factors for patients with myelodysplastic syndromes (MDS) have been identified in previous years. In order to determine prognostic factors…”
Get full text
Journal Article -
3
Polymorphisms of Cx(3)CR1 and CXCR6 receptors in relation to HAART therapy of HIV type 1 patients
Published in AIDS research and human retroviruses (01-08-2007)“…The chemokine polymorphisms CXCR6-3E/K, In1.1T/C, H7 haplotype, CX(3)CR1-V249I, and CX(3)CR1-T280M have been shown to affect the course of HIV infection. We…”
Get more information
Journal Article -
4
CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy
Published in Journal of clinical virology (01-12-2005)“…The chemokine receptor polymorphisms CCR5Delta32, CXCL12 3'A, CCR2-64I and CCR5-59029 G/A have been demonstrated to affect HIV-1 infection and progression. We…”
Get full text
Journal Article -
5
Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density
Published in International journal of immunopathology and pharmacology (01-04-2005)“…Recent studies have documented that angiogenesis plays a significant role in haematological malignancies, including mylodysplastic syndromes (MDS). Basic…”
Get more information
Journal Article -
6
CCR2-64I and CXCL12 3′A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy
Published in Journal of clinical virology (01-12-2005)“…The chemokine receptor polymorphisms CCR5Δ32, CXCL12 3′A, CCR2-64I and CCR5-59029 G/A have been demonstrated to affect HIV-1 infection and progression. We…”
Get full text
Journal Article -
7
Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease
Published in Clinical chemistry and laboratory medicine (01-01-2005)“…Multiple myeloma is characterized by accelerated production of the proteolytic enzyme matrix metalloproteinase (MMP)-9. We hypothesized that myeloma-produced…”
Get more information
Journal Article